What is a 12-panel Drug Test?
A 12-panel drug test is a comprehensive drug screen that identifies drug metabolites for amphetamines, barbiturates, benzodiazepines, cocaine, marijuana, methadone, methaqualone, phencyclidine (PCP), propoxyphene, opiates, ecstasy and Oxycodone. A customized 12-panel drug test is a stringent method to deter substance abuse per health and safety guidelines that stipulate a drug-free work environment. It is important to keep in mind that this is a general list of drugs that may be in a 12 panel, but there are several variations as to what you may be tested for.
The upswell of drug abuse remains a chronic problem for many employers across different industries, underpinning the need to mandate drug-free policies that foster pre-employment testing and random drug testing procedures. Individuals who hold federal or safety-sensitive positions are generally required to submit to consistent drug testing aligned with the Department of Defense (DOD) and Department of Transportation (DOT) field regulations. In Canada, the Canadian Model for Providing a Safe Workplace is based around DOT requirements. In many cases, 5-panel drug tests are the norm; however, distinct business sectors that are particularly susceptible to accidents or injuries, and the risks involved in certain fields necessitate expanded drug testing procedures.
Employers can help foster a drug-free workplace, offsetting the exponential curve of a drug crisis that can interfere with job performance, hamper productivity, and increase potential liability. Depending on the circumstances, a 12-step panel drug test can be a viable formality in drug screening protocol combined with educational resources covering the overarching impact of drug abuse in the community.